DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck

Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that new data supporting the utility of its DecisionDx-SCC test in patients...

Related Keywords

New York ,United States ,Phoenix ,Arizona ,American ,Castle Biosciences ,Sherrif Ibrahim ,American Joint Committee On Cancer Staging Manual ,American College Of Mohs Surgery ,Linkedin ,National Comprehensive Cancer Network ,Castle Biosciences Inc ,Instagram ,Facebook ,Nasdaq ,American College ,Mohs Surgery ,Annual Meeting ,Rochester Dermatologic Surgery ,Presenting Author ,Sun Ballroom ,Sheraton Phoenix Downtown ,American Joint Committee ,Cancer Staging Manual ,Mypath Melanoma ,